Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 56, Issue 11, 2001, Pages 1077-1080

  Nayak, Anjuli S ^a,c   Schenkel, E ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b Valley Clinical Research Center   (United States)

^c Clinical Studies Bloomington Normal   (United States)

Author keywords

Antihistamines; Congestion; Desloratadine; Seasonal intermittent allergic rhinitis

Indexed keywords

DESLORATADINE; PLACEBO;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NOSE CONGESTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; CHILD; CIRCADIAN RHYTHM; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; LORATADINE; MALE; MIDDLE AGED; NASAL DECONGESTANTS; NASAL MUCOSA; NASAL OBSTRUCTION; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME; UNITED STATES;

EID: 0034748476     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2001.00082.x     Document Type: Article

References (23)

1. Allergic rhinitis: Epidemiology and natural history
2. Diagnosis and management of rhinitis: Complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology
3. Nasal obstruction as a risk factor for sleep-disordered breathing
4. Cognitive, social, and economic costs of allergic rhinitis
5. Decrements in cognitive functioning associated with seasonal allergic rhinitis
6. National guidelines needed to manage rhinitis and prevent complications
7. Clinical aspects of allergic disease: Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis
8. Selecting a decongestant
9. 1-receptor antagonist, in patients with seasonal allergic rhinitis. Assessment during the spring and fall allergy seasons
10. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: A randomized, double-blind, placebo-controlled study
11. Anti-inflammatory properties of desloratadine (DCL): Effect on eosinophil chemotaxis, adhesion and release of superoxide anions
12. 1 receptor antagonist. 1st communication: Receptor selectivity, antihistaminic activity, and antiallergenic effects
13. 1 receptor antagonist. 2nd communication: Lack of central nervous system and cardiovascular effects
14. Desloratadine has no effect on wakefulness or psychomotor performance
15. Lack of electrocardiographic effects when desloratadine and ketoconazole are coadministered
16. Desloratadine and erythromycin: Pharmacokinetics and electrocardiographic pharmacodynamic effects
17. 1-receptor antagonist
18. Complications of allergic rhinitis
19. Obstructive apneas during sleep in patients with seasonal allergic rhinitis
20. The beneficial effect of nasal breathing on exercise-induced bronchoconstriction
21. Developmental effects of impaired breathing in the face of the growing child
22. Consensus statement on the treatment of allergic rhinitis